모바일 헬스와 홈 모니터링 제10판

출판：Berg Insight 출판년월：2021년12월

・mHealth and Home Monitoring 10th Edition
모바일 헬스와 홈 모니터링 제10판

리포트목차　　　　주문/문의　　　　납기/라이센스안내

Berg Insight 「mHealth and Home Monitoring 10th Edition – 모바일 헬스와 홈 모니터링 제10판」은 건강 관리용 무선 솔루션 시장을 조사해, 관련 기업 정보나 시장 예측 등을 제공하고 있습니다.

주요 게시물

1. 만성질환 문제
   1. 개요
   2. 일반적인 만성 질환
   3. 의료 제공자 및 의료비 상환 제도
   4. 규제 환경
2. 모바일 헬스 플랫폼
3. 환자 모니터링 솔루션 제공 업체
4. 약물 치료, AED, 통합 모니터링 솔루션 제공 업체
5. 시장 분석 및 예측
   1. 시장 예측
   2. 수익 예측
   3. 시장 성장 촉진 요인 및 억제 요인
   4. 산업 동향 및 분석

45.6 million patients worldwide are remotely monitored

mHealth and Home Monitoring is the tenth consecutive report from Berg Insight that gives first-hand insights into the adoption of wireless solutions for health monitoring. This strategic research report from Berg Insight provides you with 290 pages of unique business intelligence including 5-year industry forecasts and expert commentary on which to base your business decisions.

mHealth refers to the application of telecommunications in medicine and includes everything from connected medical devices to digital care programs. The adoption of mHealth solutions in healthcare is driven by a wide range of incentives, related to everything from demographics and technology development to new advancements in medical treatment. The primary focus of this report is on home monitoring solutions, which are commonly used to manage patients with various chronic conditions such as cardiac arrhythmia, sleep apnoea and diabetes. Other applications include remote diagnostics, compliance monitoring and clinical trials.

The number of remotely monitored patients reached 45.6 million in 2020 as the market acceptance continues to grow. This number includes all patients enrolled in mHealth care programs in which connected medical devices are used as a part of the care regimen. Berg Insight estimates that the number of remotely monitored patients will grow at a compound annual growth rate (CAGR) of 16.8 percent to reach 115.7 million by 2026. Cellular connectivity remains the de-facto standard communications technology for most types of connected home medical monitoring devices and will account for 51.0 million connections in 2026.

However, the use of patients’ own mobile devices as health hubs has become a viable alternative for remote patient monitoring and BYOD connectivity is already the preferred option in some segments. By 2026 a total of 60.5 million patients will rely on BYOD connectivity.

Berg Insight estimates that revenues for remote patient monitoring (RPM) solutions reached € 27.8 billion in 2020, including revenues from medical monitoring devices, mHealth connectivity solutions, care delivery platforms and mHealth care programs. RPM revenues are expected to grow at a CAGR of 11.6 percent between 2020 and 2026 to reach € 53.7 billion at the end of the forecast period.

Connected medical devices accounted for 64 percent of total RPM revenues in 2020. However, revenues for mHealth connectivity solutions, care delivery platforms and mHealth care programs are growing at a faster rate and will account for 55 percent of total revenues in 2023, up from just 36 percent in 2020.

There is a strong trend towards incorporating more connectivity in medical devices in order to enable new services and value propositions. Sleep therapy is by far the most connected segment and is dominated by ResMed and Philips. The number of monitored patients continues to grow and has more than doubled since 2017, largely due to the compliance monitoring requirements that have been introduced in the US and France. Implantable cardiac rhythm management (CRM) has traditionally been the largest market segment, led by companies such as Medtronic, Abbott, Boston Scientific and Biotronik that included connectivity in CRM solutions two decades ago. Berg Insight predicts that three of the fastest growing market segments in the next six years will be glucose monitoring, airflow monitoring and connected medication solutions. Today, the leading connected healthcare players in these segments include forward-thinking incumbents as well as innovative new entrants such as Abbott, AdhereTech, Dexcom, Glooko, Hero, Insulet, Medtronic, Merck Group, Propeller Health, Senseonics and WellDoc.

Care delivery platforms are one of the most rapidly developing parts of the mHealth value chain. Care delivery platforms are software solutions that enable the remote delivery of healthcare services. There are various types of care delivery platforms available on the market. General-purpose platforms can be adapted to a wide variety of use cases and are often used as the basis for developing therapy-specific mHealth products. Companies that specialise in this area include Bepatient, CareSimple, ERT, S3 Connected Health and Voluntis.

Healthcare systems around the world are currently undergoing a major transformation. The adoption of valuebased care is spreading, and healthcare providers are looking for new solutions to provide cost-efficient and improved care. In response to this, the use of data-driven solutions to optimise healthcare is increasing. One example is the use of self-engagement apps that rely on behavioural analytics to coach patients in how to manage their conditions.

The demand for remote patient monitoring has been further accelerated by the COVID-19 pandemic. As a result, we now see an increased acceptance as well as changed regulations in favour of remote patient monitoring. Berg Insight believes that this transformation will spur the adoption of mHealth solutions and expects healthy growth in the mHealth industry in the next six years.

목차

Table of contents

Executive summary

1 The challenge of chronic diseases

1.1 Introduction
1.1.1 The ageing world population
1.1.2 Lifestyle-related diseases
1.2 Common chronic diseases
1.2.1 Cardiac arrhythmia
1.2.2 Ischemic diseases
1.2.3 Hypertension
1.2.4 Sleep apnoea
1.2.5 Chronic respiratory diseases
1.2.6 Diabetes
1.2.7 Hyperlipidaemia
1.3 Healthcare providers and reimbursement systems
1.3.1 Healthcare in Asia-Pacific
1.3.2 Healthcare in Europe
1.3.3 Healthcare in North America
1.4 Regulatory environment
1.4.1 Regulatory environment in Europe
1.4.2 Regulatory environment in the US
1.4.3 Regulatory environment in other major markets
1.4.4 International standardisation

2 mHealth platforms

2.1 Overview of the mHealth market
2.1.1 mHealth market segments
2.1.2 Connectivity options for medical devices
2.1.3 The mHealth technology value chain
2.2 mHealth connectivity solutions
2.2.1 Alphabet
2.2.2 Apple
2.2.3 Ericsson
2.2.4 Deutsche Telekom
2.2.5 eDevice
2.2.6 Enovacom (Orange Healthcare)
2.2.7 KORE
2.2.8 MedM
2.2.9 Microsoft
2.2.10 PTC
2.2.11 Telenor Connexion
2.2.12 Vodafone
2.3 mHealth care delivery platforms
2.3.1 AT&T
2.3.2 Bepatient
2.3.3 CareSimple
2.3.4 Domicalis
2.3.5 Enovation (Verklizan)
2.3.6 ERT (Exco InTouch)
2.3.7 Get Real Health
2.3.8 Medixine
2.3.9 OpenTeleHealth
2.3.10 S3 Connected Health
2.3.11 Voluntis

3 Physiological monitoring solution providers

3.1 Medical devices and remote monitoring
3.1.1 Medical device revenues by market segment
3.1.2 Overview of the remote patient monitoring market
3.2 Cardiac rhythm management
3.2.1 Overview of the CRM device market
3.2.2 Use cases for CRM monitoring
3.2.3 Remote monitoring solution providers
3.2.4 Abbott (St. Jude Medical)
3.2.5 Biotronik
3.2.6 Boston Scientific
3.2.7 Medtronic
3.2.8 MicroPort (LivaNova)
3.3 Remote ECG monitoring
3.3.1 Overview of the remote ECG monitoring device market
3.3.2 Use cases for remote ECG monitoring
3.3.3 Remote monitoring solution providers
3.3.4 AliveCor
3.3.5 BioTelemetry
3.3.6 Biotricity
3.3.7 CardioComm Solutions
3.3.8 GE Healthcare
3.3.9 iRhythm Technologies
3.3.10 LevMed
3.3.11 Preventice Solutions
3.3.12 ScottCare
3.3.13 TZ Medical
3.3.14 Zenicor
3.4 Blood pressure monitoring
3.4.1 Overview of the blood pressure monitoring device market
3.4.2 Use cases for blood pressure monitoring
3.4.3 Remote monitoring solution providers
3.4.4 A&D Medical
3.4.5 iHealth Labs
3.4.6 Microlife
3.4.7 Omron Healthcare
3.4.8 Rossmax
3.4.9 Welch-Allyn
3.4.10 Withings
3.5 Coagulation monitoring
3.5.1 Overview of the coagulation monitoring device market
3.5.2 Use cases for blood coagulation monitoring
3.5.3 Remote monitoring solution providers
3.5.4 CoaguSense
3.5.5 Helena Laboratories
3.5.6 iLine Microsystems
3.5.7 Roche Diagnostics
3.5.8 Siemens Healthineers
3.5.9 Werfen (Instrumentation Laboratory)
3.6 Sleep therapy monitoring
3.6.1 Overview of the sleep therapy device market
3.6.2 Use cases for sleep therapy monitoring
3.6.3 Remote monitoring solution providers
3.6.4 Drive DeVilbiss Healthcare
3.6.5 Fisher & Paykel Healthcare
3.6.6 Löwenstein Medical Technology
3.6.7 Philips Sleep and Respiratory Care
3.6.8 ResMed
3.6.9 SRETT
3.6.10 SomnoMed
3.7 Home sleep diagnostics
3.7.1 Overview of the home sleep diagnostics market
3.7.2 Use cases for home sleep diagnostics
3.7.3 Remote monitoring solution providers
3.7.4 BioSerenity
3.7.5 Cadwell Laboratories
3.7.6 CleveMed
3.7.7 Compumedics
3.7.8 Itamar Medical
3.7.9 Natus Medical
3.7.10 Nox Medical
3.7.11 SOMNOmedics
3.8 Blood oxygen monitoring
3.8.1 Overview of the blood oxygen monitoring device market
3.8.2 Use cases for blood oxygen monitoring
3.8.3 Remote monitoring solution providers
3.8.4 ChoiceMMed
3.8.5 Masimo
3.8.6 Nonin Medical
3.9 Airfl ow monitoring
3.9.1 Overview of the air flow monitoring device market
3.9.2 Use cases for airflow monitoring
3.9.3 Remote monitoring solution providers
3.9.4 AstraZeneca
3.9.5 Adherium
3.9.6 Circassia Group
3.9.7 Medical International Research
3.9.8 NDD Medical Technologies
3.9.9 Propeller Health
3.9.10 Respiri
3.9.11 Sibelmed
3.9.12 Vitalograph
3.10 Glucose level monitoring
3.10.1 Overview of the glucose monitoring device market
3.10.2 Use cases for glucose monitoring
3.10.3 Remote monitoring solution providers
3.10.4 Abbott Diabetes Care
3.10.5 Ascensia Diabetes Care
3.10.6 BioTel Care
3.10.7 Dexcom
3.10.8 Glooko
3.10.9 Insulet
3.10.10 LifeScan
3.10.11 Medtronic Diabetes Operating Unit
3.10.12 Roche Diabetes Care
3.10.13 Senseonics
3.10.14 WellDoc
3.11 Other
3.11.1 Implantable medical devices
3.11.2 Home hemodialysis
3.11.3 Thermometers and weight scales
3.11.4 Mental health
3.11.5 Cholesterol monitoring

4 Medication, AED and integrated monitoring solution providers

4.1 Telehealth and multiparameter monitoring solutions
4.1.1 Overview of the telehealth solutions market
4.1.2 Use cases for telehealth solutions
4.1.3 Telehealth solution providers
4.1.4 Biofourmis
4.1.5 Care Innovations
4.1.6 Current Health
4.1.7 LindaCare
4.1.8 Livongo
4.1.9 Medtronic Care Management Services
4.1.10 Philips Enterprise Telehealth
4.1.11 Raziel (Ideal Life)
4.1.12 Resideo Technologies (Honeywell Life Care Solutions)
4.1.13 SHL Telemedicine
4.1.14 Telefónica
4.1.15 Tunstall Healthcare Group
4.1.16 Vitagroup
4.1.17 Vivify Health
4.2 Medication compliance monitoring
4.2.1 Overview of the medication compliance monitoring market
4.2.2 Use cases for medication compliance monitoring
4.2.3 Compliance monitoring solution providers
4.2.4 AceAge
4.2.5 AdhereTech
4.2.6 Compliance Meds Technologies
4.2.7 Emma Health Technologies
4.2.8 Evondos
4.2.9 etectRx
4.2.10 Hero
4.2.11 Merck Group
4.2.12 SMRxT
4.2.13 Spencer Health Solutions
4.2.14 Vaica
4.3 Connected automated external defi brillators
4.3.1 Overview of the connected defibrillator market
4.3.2 Use cases for automated external defibrillators
4.3.3 Connected solutions providers
4.3.4 AEDMAP
4.3.5 Almas Industries
4.3.6 Cardia International
4.3.7 CardiLink
4.3.8 Metrax
4.3.9 Nihon Kohden
4.3.10 Philips Therapeutic Care
4.3.11 Physio-Control (Stryker)
4.3.12 Pyrescom
4.3.13 Schiller
4.3.14 Zoll Medical Corporation

5 Market analysis and forecasts

5.1 Market forecasts
5.1.1 Cardiac rhythm management
5.1.2 Sleep therapy
5.1.3 Telehealth and multiparameter monitoring
5.1.4 ECG monitoring
5.1.5 Glucose level monitoring
5.1.6 Medication compliance monitoring
5.1.7 Other medical devices
5.2 Revenue forecasts
5.2.1 Medical monitoring devices
5.2.2 mHealth connectivity solutions
5.2.3 Care delivery platforms
5.2.4 mHealth care programs
5.3 Market drivers and barriers
5.3.1 An ageing population is raising medical costs
5.3.2 Increase of non-communicable disease prevalence
5.3.3 The generational technology barrier is disappearing
5.3.4 Healthcare staff shortages calls for more efficient healthcare
5.3.5 Alignment of financial incentives
5.3.6 Transformation to value-based care
5.3.7 Increased focus on disease prevention
5.3.8 Substitutes to medical monitoring
5.3.9 A slowly changing industry
5.3.10 Cybersecurity risks with more digital solutions
5.3.11 Digitalisation of PSTN networks and decommission of 2G/3G networks
5.4 Industry trends and analysis
5.4.1 Consumerisation of medical-grade mHealth devices and apps
5.4.2 From frequent readings to AI-driven patient engagement
5.4.3 Major pharmaceutical companies prepare large-scale rollouts
5.4.4 BYOD is becoming a popular and viable option
5.4.5 The global adoption of telehealth is ramping up
5.4.6 Integrations are becoming crucial in the health data ecosystem
5.4.7 Compliance monitoring is a major driver behind home monitoring
5.4.8 COVID-19 became a catalyst that took mHealth into the next growth phase

Glossary

List of Figures

Figure 1.1: Population estimates and share older than 65 years (1960-2050) ….. 4
Figure 1.2: Prevalence of metabolic syndrome conditions among adults (2018) …. 5
Figure 1.3: Direct and indirect costs of chronic diseases (US+EU) ……… 7
Figure 1.4: Number of people suffering from chronic diseases (EU/US 2017-2020) ….. 12
Figure 1.5: Share of the population covered by private health insurance (2020) ….. 16
Figure 1.6: Healthcare expenditure per capita by country (2020) …….. 18
Figure 1.7: Total and per capita healthcare expenditure by country (2019) ……. 20
Figure 1.8: Healthcare spending by type of service and product (US 2019) …… 22
Figure 2.1: mHealth market segments ……………. 33
Figure 2.2: Connected medical devices and the provision of care ……… 35
Figure 2.3: Overview of the mHealth technology value chain …….. 36
Figure 2.4: Main focus areas of mHealth connectivity solution providers …….. 40
Figure 2.5: Example of apps that can be connected to Google Fit ……… 42
Figure 2.6: HealthGO by eDevice ……………… 48
Figure 2.7: MedM applications ……………. 53
Figure 2.8: The bepatient.connect app……………. 60
Figure 2.9: The CareSimple Patient App ……………. 62
Figure 2.10: The Ellie home dashboard ………….. 66
Figure 2.11: Medixine Suite ……………… 69
Figure 3.1: Medical device market revenues by segment (World 2020-2026) …… 76
Figure 3.2: Connected medical devices by segment (World 2020) …….. 77
Figure 3.3: Implantable cardiac rhythm management vendor market shares (2020) ….. 78
Figure 3.4: Examples of implantable CRM devices ………… 80
Figure 3.5: The Medtronic MyCareLink patient monitor ……….. 81
Figure 3.6: Market shares for remote monitoring of CRM implants (2020) …… 82
Figure 3.7: The Merlin.net interface and Merlin@home transmitter …….. 84
Figure 3.8: The CardioMessenger Smart device …………. 86
Figure 3.9: Latitude NXT Wave wireless communicator ……….. 88
Figure 3.10: MCT sensor and monitor from BioTelemetry ………. 93
Figure 3.11: Implantable Cardiac Monitors from Medtronic ……….. 94
Figure 3.12: AliveCor’s KardiaMobile and Kardia App ………. 97
Figure 3.13: HeartCheck devices from CardioComm Solutions …….. 102
Figure 3.14: Examples of blood pressure monitors ………… 111
Figure 3.15: Omron Healthcare’s connected product family ………. 117
Figure 3.16: Sleep therapy vendor market shares (2020) ………… 125
Figure 3.17: ResMed AirSense 10 CPAP device and AirFit masks ……. 127
Figure 3.18: Connected sleep therapy solutions by vendor (2020) ……… 129
Figure 3.19: DreamMapper mobile application …………. 133
Figure 3.20: ResMed myAir with the Care Check-In and Personal Therapy Assistant …. 137
Figure 3.21: SomnoDent Fusion ……………… 140
Figure 3.22: Itamar Medical’s connected home sleep monitoring device …….. 142
Figure 3.23: Examples of home sleep diagnostics companies and products ….. 144
Figure 3.24: The Nox T3s Device …………….. 150
Figure 3.25: iSpO2 and MightySat device and application ………. 155
Figure 3.26: Turbu+ inhaler sensor and app …………. 161
Figure 3.27: Propeller Health’s asthma management app and inhaler sensor …. 165
Figure 3.28: Respiri’s device and asthma management app ………. 166
Figure 3.29: Blood glucose meter vendor market shares (2020) ………. 169
Figure 3.30: CGM and insulin delivery system vendor market shares (2020) …… 170
Figure 3.31: Medication usage by diabetes patients (US 2011) …….. 171
Figure 3.32: Glucose meters from Livongo and Roche ………. 172
Figure 3.33: Dexcom G6 CGM system ………….. 173
Figure 3.34: Medtronic’s MiniMed 780G integrated insulin delivery system ….. 174
Figure 3.35: Examples of connected blood glucose meters …….. 175
Figure 3.36: Examples of connected CGM and insulin pump systems …… 176
Figure 3.37: FreeStyle Libre 2 CGM system ………… 178
Figure 3.38: Dexcom G6 family ……………. 181
Figure 3.39: The Glooko Transmitter ………….. 183
Figure 3.40: Roche Accu-Chek Connect app …………. 189
Figure 3.41: WellDoc BlueStar ……………… 192
Figure 4.1: Overview of the telehealth and multiparameter monitoring landscape …. 198
Figure 4.2: Installed base of telehealth hubs by region (2020) ………. 199
Figure 4.3: The Health Harmony solution ……………. 202
Figure 4.4: Livongo’s device family and apps ………… 206
Figure 4.5: eCareCompanion and eCareCoordinator ………… 209
Figure 4.6: The Genesis Touch telehealth monitor …………. 212
Figure 4.7: Compliance monitoring solution form factors ………… 221
Figure 4.8: Connected medication compliance solutions by vendor (2020) …. 222
Figure 4.9: The AdhereTech Aidia bottle ………….. 224
Figure 4.10: The CleverCap Pro dispenser …………. 226
Figure 4.11: The EMMA E-Kit medication management system …….. 227
Figure 4.12: The Evondos E300 Automatic Medicine Dispenser ………. 229
Figure 4.13: The Easypod injector and the Easypod transmitter ………. 233
Figure 4.14: The HS1 Wireless Monitoring Cabinet ………… 238
Figure 4.15: The DOC defibrillator from Almas Industries ………… 239
Figure 5.1: Connected home medical monitoring devices (World 2020-2026) …… 248
Figure 5.2: Connected home medical monitoring devices by region (World 2020-2026).. 249
Figure 5.3: Connected cardiac rhythm management devices (World 2020-2026) …. 250
Figure 5.4: Connected sleep therapy devices (World 2020-2026) ……. 252
Figure 5.5: Telehealth hubs (World 2020-2026) ………… 253
Figure 5.6: Connected ECG monitoring devices (World 2020-2026) …… 255
Figure 5.7: Connected glucose monitoring devices (World 2020-2026) ……. 256
Figure 5.8: Connected medication monitoring solutions (World 2020-2026) …… 258
Figure 5.9: Other connected medical devices (World 2020-2026) ……. 259
Figure 5.10: Remote patient monitoring revenues (World 2020-2026) ……. 260
Figure 5.11: Connected medical device revenues (World 2020-2026) …… 261
Figure 5.12: mHealth connectivity solution revenues (World 2020-2026) …….. 262
Figure 5.13: Care delivery platform revenues (World 2020-2026) …….. 263
Figure 5.14: Monitoring service revenues (World 2020-2026) …….. 264